Research and Development
Aphton Corp.
Develops products using vaccine-like technology for neutralizing hormones which participate in gastrointestinal system and reproductive system cancer and non-cancer diseases and th…
Archemix Corp.
Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and co…
Arena Pharmaceuticals, Inc.
Receptor-based drug discovery in the fields of diabetes, obesity, cardiovascular, sleep disorders, neurodegeneration, schizophrenia, depression and anxiety. Comprehensive profile o…
AusAm Biotechnologies, Inc.
Developing diagnostics and drugs from core discoveries in protein and polysaccharide chemistry, including anti-viral attachment inhibitors. Includes research overview, distributors…
AVI Biopharma, Inc.
Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular,…
Avigen, Inc.
Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipel…
BioMep Inc.
Company founded in 1997 to develop new therapies for bone diseases. Outlines products under development and news from Montreal, Canada.
BioSphings AG.
Development and marketing of products to treat viral infections, cancer and autoimmune diseases. Features product pipeline and company details. Frankfurt, Germany.
Curis, Inc
Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data an…
Cyano Biotech GmbH.
Identifies and characterises structural variants of polyketides and non-ribosomal cyclic heptapeptides from cyanobacteria, and optimises pharmacological activity using biocombinato…
EntreMed, Inc.
Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing b…
Genelabs Technologies, Inc.
Discovers, develops and commercializes therapies for systemic lupus erythematosus, viral diseases and cancer. Located in Redwood City, California.(Nasdaq: GNLB)
Genentech, Inc.
Genetic engineering techniques in the discovery, development, production, and marketing of human therapeutics. Includes research history, product pipline, global corporate and care…
Hemobiotech Inc.
Developer of blood substitute, aiming to address intrinsic hemoglobin toxicity. Introduction to company and their work, with form to contact Dallas, Texas.
Imclone Systems Inc.
Researches and develops growth factor blockers and anti-cancer vaccines. Includes clinical programs, investor details and overview of company in New York City. (Nasdaq: IMCL)
Intra-Cellular Therapies, Inc.
Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts for headquarters i…
Intrabiotics Pharmaceuticals, Inc.
Develops antibacterial and antifungal drugs, including protegrins and related antimicrobial peptides, for application in cystic fibrosis. Includes pipeline, publications, and inves…
Showing 20–20 of 37 results